Treatment options and prognostic risk factors for urachal carcinoma: A multicetnter retrospective study
CONCLUSIONS: EPC or RC provides similar oncologic results for UC, but bilateral pelvic lymph node dissection is not necessary in early-stage patients. Postoperative adjuvant chemotherapy can significantly reduce the recurrence rate, and combination therapy may provide better survival outcomes. CA724 can predict tumor recurrence or metastasis at an early stage.PMID:36283930 | DOI:10.1016/j.urolonc.2022.09.017
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Chunjin Ke Lu Xu Maoyu Wang Yinzhao Wang Qian Zhou Jinchao Chen Zhihua Wang Shaogang Wang Zhiquan Hu Chunguang Yang Source Type: research
More News: Cancer | Cancer & Oncology | Carbohydrates | Carcinoma | Chemotherapy | Databases & Libraries | Study | Urachal Carcinoma | Urology & Nephrology